Exploring the origin of the cancer stem cell niche and its role in anti-angiogenic treatment for glioblastoma
Authors:
Open Access
- 25 August 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 12, 947634
Abstract
Cancer stem cells are thought to be the main drivers of tumorigenesis for malignancies such as glioblastoma (GBM). They are maintained through a close relationship with the tumor vasculature. Previous literature has well-characterized the components and signaling pathways for maintenance of this stem cell niche, but details on how the niche initially forms are limited. This review discusses development of the nonmalignant neural and hematopoietic stem cell niches in order to draw important parallels to the malignant environment. We then discuss what is known about the cancer stem cell niche, its relationship with angiogenesis, and provide a hypothesis for its development in GBM. A better understanding of the mechanisms of development of the tumor stem cell niche may provide new insights to potentially therapeutically exploit.Keywords
This publication has 134 references indexed in Scilit:
- Basic and Therapeutic Aspects of AngiogenesisCell, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Genetically Engineered Mouse Models of Brain Cancer and the Promise of Preclinical TestingBrain Pathology, 2008
- A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human OrgansCell Stem Cell, 2008
- Diffuse glioma growth: a guerilla warActa Neuropathologica, 2007
- Haematopoietic stem cells do not asymmetrically segregate chromosomes or retain BrdUNature, 2007
- Angiogenesis-independent tumor growth mediated by stem-like cancer cellsProceedings of the National Academy of Sciences, 2006
- Stem Cell–like Glioma Cells Promote Tumor Angiogenesis through Vascular Endothelial Growth FactorCancer Research, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996